Advertisement
Screener

CONTEXT THERAPEUTICS INC. (CNTX) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

CONTEXT THERAPEUTICS INC. Capital Expenditures

CONTEXT THERAPEUTICS INC. (CNTX) reported Capital Expenditures of $55.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05

  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $18.49K.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $37.26K, a 9.75% increase year-over-year.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $33.95K, a 364.02% increase from fiscal 2024.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $7.32K.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • CONTEXT THERAPEUTICS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $36.84K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$18.49K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$55.75K
10-Q · filed 2026-08-05
$55.75K
derived: sum of 3 quarters · filed 2026-08-05
$55.75K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$37.26K
10-Q · filed 2026-05-06
$37.26K
derived: sum of 2 quarters · filed 2026-05-06
$37.26K
derived: sum of 3 quarters · filed 2026-05-06
$37.26K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
$0.00
derived: sum of 2 quarters · filed 2026-03-23
$0.00
derived: sum of 3 quarters · filed 2026-08-05
$33.95K
10-K · filed 2026-03-23
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$0.00
derived: sum of 2 quarters · filed 2026-08-05
$33.95K
10-Q · filed 2025-11-05
$33.95K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$33.95K
10-Q · filed 2026-08-05
$33.95K
derived: sum of 3 quarters · filed 2026-08-05
$41.26K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$33.95K
10-Q · filed 2026-05-06
$33.95K
derived: sum of 2 quarters · filed 2026-05-06
$41.26K
derived: sum of 3 quarters · filed 2026-05-06
$41.26K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
$7.32K
derived: sum of 2 quarters · filed 2026-03-23
$7.32K
derived: sum of 3 quarters · filed 2026-03-23
$7.32K
10-K · filed 2026-03-23
2024-09-30$7.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$7.32K
derived: sum of 2 quarters · filed 2025-11-05
$7.32K
10-Q · filed 2025-11-05
$7.32K
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$0.00
10-Q · filed 2025-08-06
$0.00
derived: sum of 3 quarters · filed 2025-08-06
$0.00
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$0.00
10-Q · filed 2025-05-07
$0.00
derived: sum of 2 quarters · filed 2025-05-07
$0.00
derived: sum of 3 quarters · filed 2025-05-07
$0.00
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$0.00
derived: sum of 2 quarters · filed 2025-03-20
$0.00
derived: sum of 3 quarters · filed 2025-03-20
$0.00
10-K · filed 2025-03-20
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$0.00
derived: sum of 2 quarters · filed 2024-11-06
$0.00
10-Q · filed 2024-11-06
$0.00
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$0.00
10-Q · filed 2023-08-09
$0.00
derived: sum of 3 quarters · filed 2024-03-21
$0.00
derived: sum of 4 quarters · filed 2024-03-21
2023-03-31$0.00
10-Q · filed 2023-05-10
$0.00
derived: sum of 2 quarters · filed 2024-03-21
$0.00
derived: sum of 3 quarters · filed 2024-03-21
$1.84K
derived: sum of 4 quarters · filed 2024-03-21
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$0.00
derived: sum of 2 quarters · filed 2024-03-21
$1.84K
derived: sum of 3 quarters · filed 2024-03-21
$36.84K
10-K · filed 2024-03-21
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$1.84K
derived: sum of 2 quarters · filed 2023-11-09
$36.84K
10-Q · filed 2023-11-09
$36.84K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.84K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$36.84K
10-Q · filed 2023-08-09
$36.84K
derived: sum of 3 quarters · filed 2023-08-09
$36.84K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$35.00K
10-Q · filed 2023-05-10
$35.00K
derived: sum of 2 quarters · filed 2023-05-10
$35.00K
derived: sum of 3 quarters · filed 2023-05-10
$35.00K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$0.00
derived: sum of 2 quarters · filed 2023-03-22
$0.00
derived: sum of 3 quarters · filed 2023-03-22
$0.00
10-K · filed 2023-03-22
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$0.00
10-Q · filed 2022-08-11
2021-03-31$0.00
10-Q · filed 2022-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
NANOVIRICIDES, INC. (NNVC)United States$0.031B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
BriaCell Therapeutics Corp. (BCTX)$0.037B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05